Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Co-Diagnostics, DNA Logix ink acquisition agreement
June 2013
SHARING OPTIONS:

SALT LAKE CITYŚCo-Diagnostics Inc. has announced an agreement with molecular diagnostic assay developer DNA Logix for the acquisition of certain technologies for genetic analysis in the clinical, industrial and biothreat markets. The technology to be acquired includes three patent applications and certain trade secrets, and was created by Dr. Brent C. Satterfield, founder of DNA Logix. No financial details regarding the transaction were disclosed.  
 
"We are pleased to announce this technology acquisition from DNA Logix. With this technology, we believe our highly efficient assay development capability, combined with superior results and efficient costs, will result in our unique approach to DNA testing being sought after by developers of powerful diagnostics in a wide range of markets," said Dwight Egan, president of Co-Diagnostics, in a press release.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
478 Bay Street, Suite A213
Midland, Ontario, Canada L4R 1K9
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.